PrisMax 2 (Prismaflex)

In the ICU, innovation influences patient care.

What If patient care inspired innovation?

Get in touch

Introducing the PrisMax 2 system: a familiar system with enhanced capabilities

Designed based on feedback from healthcare professionals like you, the PrisMax 2 system brings a world of new possibilities within extracorporeal therapies and user experience, building upon the proven Prismaflex system.

Explore what’s new compared to your existing Prismaflex system

PrisMax 2 machine monitor with the therapy screen seen from the front

Enhanced interface

Intuitive user interface with step-by-step on-screen instructions guides you through seamless therapy delivery

Left side of the PrisMax 2 machine focussing on the Auto-Effluent Drain

Reduced interventions

The Auto-Effluent Drain reduces device interactions and decreases therapy downtime to allow more time for patient care1

Right side of the PrisMax 2 machine focussing on the TherMax Blood Warmer

Effective warming

The TherMax Blood Warmer allows for effective warming for CRRT and other organ support therapies1

PrisMax 2 machine seen from the side focussing on the monitor and rotation

Adjustable touchscreen

Large rotating touchscreen with safety features and color-coded data for easy visibility

PrisMax 2 machine in  view from the front with custom therapy profiles

Simplified operations

Custom therapy profiles to help ensure consistency of therapy delivery and adherence to prescriptions1 

PrisMax 2 machine in a hospital hall setting with backlighting

Smooth transition to the PrisMax 2 system

As a busy clinician, you want to limit potential disruptions in terms of workflow and nurse training that can come with switching to a new system. Rest assured. The PrisMax 2 system is built on the workflow you know as a Prismaflex user and comes with the service, training, and support you have come to rely on.

•    Familiar therapies & modalities

•    Continued use of same disposables and fluids

•    Similar alarm management

These commonalities help reduce training time for nurses. 

What’s more — you can continue to drive efficiencies in your ICU as you add new PrisMax 2 systems to your existing fleet of Prismaflex systems — owing to common inventory and familiar modalities. 

Driving purposeful innovation in critical care: Introducing two solutions powered by the PrisMax 2 system

Doctor and Baxter sales representative talking about avarage filter life looking at ipad

Enjoy wireless EMR Connectivity

Save time that can be refocused on patient care with TrueVue Connect, a digital add-on communication module for the PrisMax 2 system, which simplifies auto-documentation with enhanced EMR connectivity.

Doctor and nurse looking at a grafical illustration of the lungs and kidneys

Add integrated ECCO2R therapy for your critical care patients1

With the PrismaLung+ gas exchanger on the PrisMax 2 system, you can now deliver ECCO₂R therapy to help manage hypercapnia and respiratory acidosis.

Meet the capabilities of the PrisMax 2 system

IMPORTANT SAFETY INFORMATION

The PrisMax control unit is intended for:
• Continuous Renal Replacement Therapy (CRRT) for patients with acute renal failure and/or fluid overload
• Therapeutic Plasma Exchange (TPE) therapy for patients with diseases where removal of plasma components is indicated
• Hemoperfusion (HP) for patients with conditions where immediate removal of substances by adsorption is indicated
• Extracorporeal CO2 Removal (ECCO2R) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated

The Prismaflex control unit is intended for:
• Continuous Renal Replacement Therapy for patients with acute renal failure and/or fluid overload
• Therapeutic Plasma Exchange Therapy for patients with diseases where removal of plasma components is indicated
• Hemoperfusion for patients with conditions where immediate removal of substances by adsorption is indicated
• Hemopurification for patients with conditions where extracorporeal elimination of carbon dioxide is indicated

The PrismaLung+ device is indicated to provide extracorporeal CO2 removal (ECCO2R) as a stand-alone therapy or in combination with Continuous Renal Replacement Therapy (CRRT). It is intended for patients with increased levels of CO2 in their blood and with a body weight greater than or equal to 30 kg (66 lb).

TherMax is intended for use in combination with the PrisMax control unit using Prismaflex blood tubing sets for the warming of blood during extracorporeal blood circulation.

For safe and proper use of the products mentioned herein, please refer to the Operator’s Manual or Instructions for Use.

 

PrismaflexPrisMax, Prismalung+ and Thermax